Variable | Category | Case (n = 64) | Control (n = 256) | COR (95% CI) | AOR (95% CI) |
---|---|---|---|---|---|
Age of the mother | < 25 years | 14(21.9%) | 83(32.4%) | 1 | 1 |
25–35 years | 36(56.2%) | 165(64.5%) | 1.3(0.66–2.53) | 1.5(0.65–3.56) | |
> 35 years | 14(21.9%) | 8(3.1%) | 10.4(3.68–29.26) | 8.8(1.99–38.78)* | |
Place of residence | Urban | 43(67.2%) | 124(48.4%) | 2.2(1.23–3.88) | 2.4(1.23–4.82)* |
Rural | 21(32.8%) | 132(51.6%) | 1 | 1 | |
Sex of neonate | Male | 53(82.8%) | 152(59.4%) | 3.3(1.64–6.61) | 4.3(1.90–9.74)** |
Female | 11(17.2%) | 104(40.6%) | 1 | 1 | |
Parity | Primiparous | 21(32.8%) | 120(46.9%) | 1 | 1 |
Multiparous | 43(67.2%) | 136(53.1%) | 1.8(1.01–3.22) | 1.42(0.65–3.10) | |
Any complications during pregnancy? | Yes | 33(51.6%) | 76(29.7%) | 2.5(1.44–4.4) | 1.92(0.94–3.90) |
No | 31(48.4%) | 180(70.3%) | 1 | 1 | |
Mode of delivery | Vaginal delivery | 50(78.1%) | 185(72.3%) | 1 | 1 |
C/S | 5(7.8%) | 48(18.7%) | 0.4(0.15–1.02) | 0.24(0.08–0.72)* | |
Instrumental | 9(14.1%) | 23(9%) | 1.4(0.63–3.32) | 2.1(0.74–5.71) | |
Oxytocin use during labor | Yes | 18(28.1%) | 47(18.4%) | 1.7(0.93–3.27) | 1.8(0.79–4.10) |
No | 46(71.9%) | 209(81.6%) | 1 | 1 | |
Gestational age | < 37 weeks | 30(46.9%) | 57(22.3%) | 3.1(1.74–5.46) | 3.9(1.88–8.09)** |
≥ 37 weeks | 34(53.1%) | 199(77.7%) | 1 | 1 | |
Rh status of the mother | Positive | 54(84.4%) | 237(92.6%) | 1 | 1 |
Negative | 10(15.6%) | 19(7.4%) | 2.3(1.02–5.25) | 2.2(0.82–5.92) | |
ABO incompatibility | Yes | 17(26.6%) | 46(18%) | 1.6(0.87–3.13) | 2.6(1.16–5.96)* |
No | 47(73.4%) | 210(82%) | 1 | 1 |